Cardiology

Coming Soon: A Series of Cardiology Experts Knowledge Shares

COR2ED, CORONARY CONNECT and ACTION-Coeur invite you to a series of Experts Knowledge Share events on managing cardiovascular risk in myocardial infarction (MI), ischaemic stroke and diabetes patients

Prof. Gilles Montalescot

Prof. François Mach

Prof. Pepe Zamorano

Publication Date

Dec 2022

I agree that this educational programme:

Was valuable to me

1/4

Has improved my knowledge of this topic:

2/4

Is likely to change my clinical practice:

3/4

Was balanced and unbiased:

4/4

The first virtual Experts Knowledge Share event, 'Best Approaches to Treat MI Patients' will take place at 7 pm (CET) on Tuesday, 31st January 2023.

Register below to secure your place.

During the event, you'll learn about lipids management in relation to CV imaging and intervention, managing patients at very high risk of CVD, and treating LDL-C in the management of ACS with a focus on post-MI and stroke management.

To introduce the series, Prof. Pepe Zamorano shares his view on achieving optimal LDL level post-MI in the video below.

Clinical takeaways:

High cardiovascular risk post-MI is a chronic disease state, and patients need to receive long-term treatment to ensure the prevention of further cardiac events
The lower the LDL level, the better. The target is 55mg/dL in high-risk patients, but even lower than this is preferable. The LDL target level also includes a 50% reduction in baseline LDL
Guidelines suggest a 3-step approach, including high-intensity statins, Ezetimibe and PCSK9 inhibitors

Each Experts Knowledge Share event will provide a unique, high-quality scientific virtual forum for sharing knowledge and experience to support cardiologists, lipidologists and neurologists in their clinical practice.

The first event will be chaired by Prof. Gilles Montalescot, with speakers Prof. Pepe Zamorano and Prof. François Mach.

Clinical Topics

Event 1: Best approaches to treat MI patients

Event 2: Prevention and management of heart disease in T2D patients: Cardiologist and Diabetologist perspective

Event 3: Ischaemic stroke and lipids

This series of Experts Knowledge Shares is brought to you by

ACTION-Coeur - an independent not-for-profit academic research organisation (ARO) promoting knowledge in cardiology. The group was established in 2007 and is based at the Institute of Cardiology within the University Hospital La Pitié-Salpêtrière in Paris.

CORONARY CONNECT - An international group of independent experts in the field of coronary heart disease; an initiative of COR2ED.

Gilles Montalescot is Professor of Cardiology at the Pitié Salpêtrière Hospital in Paris, France, where he heads the Department of Cardiology at the Institute of Cardiology. He is a practicing Interventional Cardiologist and has extensive experience in basic and clinical research. He has been the director of the INSERM research Unit UMRS_1166 on Thrombosis for 10 years. Dr Montalescot has been an investigator for many of the new drugs developed in the past twenty years as well as for many of the new interventional technologies. Dr Montalescot is a senior scientist and has been the lead investigator of many national or international randomized trials including ADMIRAL, ARMADA, ALBION, STEEPLE, ARCHIPELAGO, ABOARD, ACAPULCO, ATOLL, ARCTIC, ANTARCTIC, ACCOAST, ATLANTIC, AEGEAN, AMERICA, ALBATROS, and the ongoing ATLANTIS, ALPHEUS, ARAMIS, ADRIFT trials. Dr Montalescot is the Chairman of the ACTION study group, an Academic Research Organization based at Pitié Salpêtrière Hospital in Paris. He has served on several task force committees on antithrombotic drugs and acute coronary syndromes and is the current Chairman of the Stable Coronary Artery disease guidelines of the European Society of Cardiology. Dr Montalescot has received several awards in his country including the J. Valade Prize from the Fondation de France and the J.Escalle award from the National Academy of Medicine. He is a member of several editorial boards and has published over 600 peer reviewed original articles in journals such as the NEJM, JAMA, Lancet. Internationally, Dr Montalescot has also been an invited speaker at plenary sessions of major congresses such as the European Society of Cardiology, the American College of Cardiology ,and the American Heart Association.

Head of Cardiology

Prof. Pepe Zamorano has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Abbott, Amgen and Bayer